[Effects of temazepam on experimental insomnia induced by methylphenidate in man]. 1982

F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord

UI MeSH Term Description Entries
D007319 Sleep Initiation and Maintenance Disorders Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition. Disorders of Initiating and Maintaining Sleep,Insomnia,Sleeplessness,Chronic Insomnia,DIMS (Disorders of Initiating and Maintaining Sleep),Early Awakening,Insomnia Disorder,Nonorganic Insomnia,Primary Insomnia,Psychophysiological Insomnia,Rebound Insomnia,Secondary Insomnia,Sleep Initiation Dysfunction,Transient Insomnia,Awakening, Early,Dysfunction, Sleep Initiation,Dysfunctions, Sleep Initiation,Insomnia Disorders,Insomnia, Chronic,Insomnia, Nonorganic,Insomnia, Primary,Insomnia, Psychophysiological,Insomnia, Rebound,Insomnia, Secondary,Insomnia, Transient,Insomnias,Sleep Initiation Dysfunctions
D008774 Methylphenidate A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE. Centedrin,Concerta,Daytrana,Equasym,Metadate,Methylin,Methylphenidate Hydrochloride,Phenidylate,Ritalin,Ritalin-SR,Ritaline,Tsentedrin,Hydrochloride, Methylphenidate,Ritalin SR
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006185 Habituation, Psychophysiologic The disappearance of responsiveness to a repeated stimulation. It does not include drug habituation. Habituation (Psychophysiology),Habituation, Psychophysiological,Psychophysiologic Habituation,Psychophysiological Habituation,Habituations (Psychophysiology)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012895 Sleep, REM A stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG. It is usually associated with dreaming. Fast-Wave Sleep,Paradoxical Sleep,Rapid Eye Movements,Rhombencephalic Sleep,Sleep, Fast-Wave,REM Sleep,Eye Movement, Rapid,Eye Movements, Rapid,Fast Wave Sleep,Movement, Rapid Eye,Movements, Rapid Eye,Rapid Eye Movement,Sleep, Fast Wave,Sleep, Paradoxical,Sleep, Rhombencephalic
D013693 Temazepam A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent. Hydroxydiazepam,Methyloxazepam,Norkotral Tema,3-Hydroxydiazepam,Apo-Temazepam,Dasuen,Euhypnos,Gen-Temazepam,Levanxol,Nocturne,Normison,Normitab,Nortem,Novo-Temazepam,Nu-Temazepam,Oxydiazepam,PMS-Temazepam,Planum,Pronervon T,Remestan,Restoril,Ro-5-5345,SaH 47-603,Signopam,Temaze,Temazep Von Ct,Temtabs,Tenox,WY-3917,3 Hydroxydiazepam,Apo Temazepam,Gen Temazepam,Novo Temazepam,Nu Temazepam,PMS Temazepam,Ro 5 5345,Ro55345,SaH 47 603,SaH 47603,Tema, Norkotral,Von Ct, Temazep,WY 3917,WY3917
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord
January 1982, Psychopharmacology,
F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord
August 1990, Arzneimittel-Forschung,
F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord
March 1978, Drug and therapeutics bulletin,
F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord
January 2003, Human psychopharmacology,
F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord
February 2005, Current medical research and opinion,
F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord
February 1982, The Medical letter on drugs and therapeutics,
F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord
January 2015, Sao Paulo medical journal = Revista paulista de medicina,
F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord
March 2001, Human psychopharmacology,
F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord
December 1973, The American journal of psychiatry,
F Laffont, and H P Cathala, and S Esnault, and A Gilbert, and M Minz, and M A Peytourg, and P Waisbord
April 2004, Current medical research and opinion,
Copied contents to your clipboard!